(Q47362832)

14 January 2018

title

Different mechanisms in weight loss-induced blood pressure reduction between a calorie-restricted diet and exercise (English)

1 reference

14 January 2018

author

Hiromi Rakugi

2

1 reference

14 January 2018

author name string

Kazuko Masuo

1

1 reference

14 January 2018

Toshio Ogihara

3

1 reference

14 January 2018

Gavin W Lambert

4

1 reference

14 January 2018

publication date

4 August 2011

1 reference

14 January 2018

published in

Hypertension Research

1 reference

14 January 2018

volume

35

1 reference

14 January 2018

issue

1

1 reference

14 January 2018

page(s)

41-47

1 reference

14 January 2018

https://scigraph.springernature.com/pub.10.1038/hr.2011.134

exact match

0 references

cites work

Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

High plasma norepinephrine levels associated with beta2-adrenoceptor polymorphisms predict future renal damage in nonobese normotensive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Sympathetic overactivity in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Long-term outcome of the Malmö preventive project: mortality and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Effects of the dietary approaches to stop hypertension diet, exercise, and caloric restriction on neurocognition in overweight adults with high blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

The DASH diet and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Weight reduction and pharmacologic treatment in obese hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Prevalence of anxiety and depressive symptoms among obese pregnant and postpartum women: an intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

The impact of obstructive sleep apnea on chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Weight gain-induced blood pressure elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Combined diet and exercise intervention reverses the metabolic syndrome in middle-aged males: results from the Oslo Diet and Exercise Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Long-term weight loss effects on all cause mortality in overweight/obese populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Long-term mortality after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Acute hyperinsulinemia reduces plasma leptin levels in insulin-sensitive Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Differences in mechanisms between weight loss-sensitive and -resistant blood pressure reduction in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Blood pressure and hormone changes associated with weight reduction in the obese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Exercise training lowers resting renal but not cardiac sympathetic activity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

BP changes in obese hypertensive subjects during rapid weight loss. Comparison of restricted v unchanged salt intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

The metabolic syndrome and the immediate antihypertensive effects of aerobic exercise: a randomized control design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Diet and exercise training restore blood pressure and vasodilatory responses during physiological maneuvers in obese children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Effects of diet and exercise training on neurovascular control during mental stress in obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

Sympathetic activation in obese normotensive subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

7 January 2021

Role of the sympathetic nervous system in human hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

7 January 2021

The spread of the obesity epidemic in the United States, 1991-1998

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

7 January 2021

Noradrenaline Release and the Pathophysiology of Primary Human Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

7 January 2021

Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

7 January 2021

Role of insulin and norepinephrine in the hypertension of obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

7 January 2021

Plasma norepinephrine and dietary sodium intake in normal subjects and patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

7 January 2021

Weight loss improves neurovascular and muscle metaboreflex control in obesity

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.134

7 January 2021

Identifiers

DOI

10.1038/HR.2011.134

1 reference

14 January 2018

PubMed ID

21814218

1 reference

14 January 2018